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PAX2 mutations in oligomeganephronia. a sporadic and isolated malformation, several lines of
Background. Oligomeganephronia (OMN) is a rare congen- evidence, namely the existence of syndromic renal hypo-
ital and usually sporadic anomaly. It is characterized by bilat- plasia including branchio-oto-renal [3], acro-renal [4], oreral renal hypoplasia, with a reduced number of enlarged neph-
renal-coloboma syndromes (RCSs) as well as the associa-rons. The mechanisms involved in this deficient nephrogenesis
tion with chromosomal abnormalities [5, 6], suggest thatare unknown. The paired box transcription factor PAX2 plays
a fundamental role in renal development. Heterozygous Pax2 genetic factors could be involved. Moreover, the descrip-
mutants in mice are characterized by renal hypoplasia and tion of some cases of familial recurrence is consistent
retinal defects, and in humans, PAX2 mutations have been with a role of genetic events in OMN [7].described in the renal-coloboma syndrome.
PAX genes encode paired box-containing transcrip-Methods. To assess whether OMN could be related to
tion factors that are critical during embryonic develop-PAX2, we searched for PAX2 mutations in nine patients pre-
senting with sporadic and apparently isolated OMN. ment. In the human embryo, PAX2 is expressed in the
Results. Heterozygous PAX2 mutations were found in three kidney as well as in the optic cup, the otic vesicle, and
patients. A limited optic nerve coloboma was secondarily de- other parts of the central nervous system [8]. Pax2 loss-tected in two cases and a very mild optic disk dysplasia in one
of-function mutations in mice (krd, Pax21Neu, and targetedpatient. None of these patients had visual impairment.
Pax2 gene knockout) are associated with renal hypopla-Conclusions. Ocular anomaly and PAX2 mutations should
be sought in all patients with OMN. sia and retinal defect [9–11]. Interestingly, the kidneys
have a reduced cortical thickness with fewer nephrons,
a feature very similar to what is observed in OMN [9].
Oligomeganephronia (OMN) is a rare congenital anom- Renal-coloboma syndrome (MIM 120330) is an auto-
aly characterized by bilateral renal hypoplasia without somal congenital anomaly characterized by the associa-
dysplasia or urinary tract abnormalities. Kidneys are tion of renal hypoplasia, vesicoureteral reflux (VUR),
small and have a normal shape on radiological examina- and optic nerve coloboma [12]. Based on the similarity
tion. Histologically, they show a striking reduction in the between this condition and the phenotype of Pax2 mu-
number of nephrons, which are markedly enlarged [1]. tant mice, PAX2 has been regarded as a good candidate
Polyuria and polydypsia appearing within the first two gene for RCS. Indeed, in 1995, Sanyanusin et al reported
years of life are the main manifestations of the disorder. heterozygous PAX2 mutations in two RCS families
The glomerular filtration rate (GFR) is impaired from [13, 14]. Thirty-two RCS patients with nine different
birth, increases progressively to a maximum during the PAX2 mutations have hitherto been reported (Table 1)
first years of life, and remains stable in early childhood, [13–20], but the absence of PAX2 mutations in some
ultimately decreasing in late childhood. The mechanisms RCS patients suggests genetic heterogeneity of the syn-
responsible for the deficit in nephrogenesis are not iden- drome (data not shown) [18]. To investigate whether
tified. They could result from a deficient metanephric PAX2 could be implicated in OMN, nine patients with
blastema [2] or from a defect in the growth and branching apparently isolated OMN were evaluated for PAX2
of the ureteric bud. Although OMN usually occurs as mutations.
Key words: coloboma, transcription factor, inheritance, renal hypopla- METHODSsia, retinal defects in Pax2, optic disk dysplasia in OMN.
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Table 1. Renal and ocular phenotype in 32 patients with PAX2 mutations
PAX2 mutation Age Renal Renal Optic nerve Visual
Patient (exon) years hypoplasia insufficiency VUR colobomaa impairment References
1 1104delC (5) 15 1 1 1 1 1 [14]
2 10 1 1 2 1 1 [14]
3 6 1 1 1 1 1 [14]
4 35 2 1 2 1 1 [14]
430 619insG (2) 5 2 1 2 1 1 [13]
431 12 2 1 2 1 1 [13]
579 674del22 (2) 11 1 1 2 1 1 [15]
656 619insG (2) 48 1 1 2 1 1 [15]
657 25 1 1 2 1 1 [15]
2646 619insG (2) 20 1 1 2 1 1 [15]
TRN t(10; 13) 5 2 1 2 1 1 [17]
985 611delT (2) 6 2 1 1 1 ND [18]
III-8 G769A (3) 70 2 1 1 1 2 [19]
IV-2 52 1 1 2 1 1 [19]
IV-3 46 1 1 2 1 2 [19]
IV-6 40 1 1 2 1 2 [19]
IV-7 35 1 1 2 1 2 [19]
V-2 16 1 1 2 1 2 [19]
F2 768ins6 (3) 17 1 1 1 1 1 [19]
I-1 C1289T (7) 70 2 1 2 1 1 [20]
II-5 37 1 1 2 1 1 [20]
II-7 40 2 2 2 1 2 [20]
II-9 39 2 1 2 1 1 [20]
III-9 14 2 2 2 1 2 [20]
III-11 18 2 2 2 1 2 [20]
III-13 21 1 1 2 1 1 [20]
III-16 4 2 2 1 1 2 [20]
III-17 6 1 1 2 1 1 [20]
X2003 619insG (2) 13 1 1 2 1 1 [20]
12961 619insG (2) 5 ND ND 1 1 1 [16]
12962 33 ND ND ND 1 1 [16]
8961 619delG (2) 4 1 1 ND 1 1 [16]
Abbreviations are: VUR, vesicoureteral reflux; ND, not determined.
a Optic disk dysplasia rather than optic nerve coloboma is present in some patients
the parents. Clinical data are presented in Table 2. Pa- directly sequenced on both strands using the fluoromet-
ric method (DyeDeoxy or BigDye Terminator Cycle Se-tients with renal hypoplasia associated with high-grade
VUR (III or more) or other renal or extrarenal malfor- quencing Kit; Applied Biosystems, Foster City, CA,
USA). To detect partial or total deletion of the gene, themations had been excluded from the study. Renal histo-
logic analysis was available on the nephrectomy speci- heterozygosity for PAX2 was analyzed in each patient
by amplification of a (CA)n dinucleotide repeat withinmens of five patients who were transplanted. It confirmed
the diagnosis of OMN by showing (1) a striking reduction intron 9 as previously described [22].
in the number of glomerular generations on strictly or-
Pax2 expression in the kidneythogonal cortico-medullary sections [21], (2) the absence
of dysplastic features, and (3) the marked enlargement To assess the consequences of the mutations on the
of preserved nephrons with glomerular and tubular di- renal expression of PAX2 protein, we performed PAX2
ameters two or three times normal (Fig. 1). immunostaining on the kidneys of five OMN patients
who progressed to end-stage renal disease (2 with and
Detection of PAX2 mutation 3 without identified PAX2 mutation). Control kidneys
were from two fetuses of 22 and 28 gestational weeksGenomic DNA was extracted from peripheral blood
lymphocytes by standard methods. Fragments spanning obtained at autopsy after spontaneous abortion or termi-
nation of pregnancy for medical reasons and six childrenthe 12 exons of PAX2 were amplified from genomic
DNA by use of intronic polymerase chain reaction or adults (3 nontransplanted kidneys and 3 normal tissue
specimens adjacent to renal carcinoma). PAX2 antibody(PCR) primers. Primer sequences and PCR conditions
have been described previously [8]. Mutation screening (Zymed Laboratories Inc., San Francisco, CA, USA)
is a rabbit antibody generated against a fusion proteinwas performed by single strand conformation polymor-
phism (SSCP) as previously described [8]. When an ab- derived from the C-terminal domain of the murine PAX2
protein. Immunostaining was performed as previouslynormal SSCP pattern was observed, genomic DNA was
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Table 2. Clinical and genetic characteristics of patients with OMN
Age at ESRF
Maximal or actual
Birthweight Kidney Circumstances of creatinine creatinine Renal Eye Other PAX2
Patient kg sizea diagnosis age clearanceb clearanceb histology VUR anomalies anomalies mutation
1 3.13 0.70 Dehydration 68 20 y no no Coloboma no 658–663del
(21) (neonatal)
2 2.60 0.60 Polyuria 15 5.5 y yes no Papillar no 619insG
(48) (4 years) dysplasia
3 3.15 0.70 Vomiting 15 7 y yes no Coloboma no 619insG
(1) (neonatal)
4 2.90 0.55 Failure to thrive 22 13 y no no no no no
(6) (neonatal)
5 4.08 0.70 Dehydration 10 6.5 y no no no no no
(24) (neonatal)
6 3.50 0.60 Acidosis 16 14 y yes no no Clubfoot no
(6) (neonatal)
7 2.70 0.55 Abdominal US 56 30 mL/min no no no Testicular ectopia, no
(birth) (neonatal) at 18 y Mental retardation
8 2.94 0.25 Oligoamnios 8 1.5 y yes no no no no
(birth) (antenatal)
9 2.87 0.55 Oligoamnios 6 3.5 y yes grade II no no no
(1) (antenatal)
a Kidney size is expressed as a fraction of the mean normal size for the same age, age is indicated in month
b Maximal creatinine clearance was calculated by means of the formula K 3 T/C, where T is the size expressed in centimeters, C represents the plasma level of
creatinine in micromoles per liter, and K stands for a constant the value of which varies according to the weight, the results are expressed in mL/min/1.73 m2; y,
year; ESRF, end-stage renal failure; VUR, vesicoureteral reflux.
Fig. 1. Silver methenamine (a), periodic acid-
Schiff stain (b), and PAX2 immunolabeling
(c and d) of normal (a and c) and oligomega-
nephronia (OMN; b and d) human kidneys. A
comparison between a and b shows a marked
increase in size of OMN nephrons. Nuclear
labeling of collecting duct cells is present in
normal adult kidney (c) and preserved in OMN
kidney (d). (Original magnification 3135).
described [23]. Three-micrometer thick deparaffinized RESULTS
sections were pretreated by microwave heating in a urea By screening the entire coding sequence of the PAX2
solution (2 3 5 min in 0.8 mol/L urea, pH 6.4). PAX2 gene in nine unrelated patients with apparently isolated
antibodies were diluted to 1/25 to 1/50. Immunoperoxi- OMN, we detected heterozygous PAX2 mutations in
dase staining was carried out using the Vectastain Elite three of them: a single nucleotide (guanosine) insertion
ABC kit (Vector, Burlingame, CA, USA). Labeling was at position 619 in two (patients 2 and 3), and a 6 nucleo-
examined with a Leitz Orthoplan microscope. Control tide deletions located in exon 2 in one (patient 1; Fig.
stainings were performed in the same conditions with 2). The guanine insertion occurred in exon 2 after a
the primary antibody omitted. No labeling was observed stretch of seven guanines and resulted in a frameshift
predicting the premature termination of the protein 27in control sections.
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Fig. 2. PAX2 mutations in OMN probands. (A)
SSCP autoradiograms showing shift of the
G619insG mutant allele (lane 4) and del6
bp658-663del allele (lane 5) compared with con-
trol (lane 1 through 3). (B) Control and mu-
tant DNA sequence analysis. (C ) Schematic
representation of the PAX2 gene coding re-
gions. The conserved paired box domain ( )
and the octapeptide domain ( ) are repre-
sented. The two mutations identified in the
present study are depicted: the insertion of a
G in position 619, which results in a frameshift
and a truncated protein within the paired do-
main, and a 6 bp deletion, which results in a two
amino acid deletion within the paired domain.
amino acids downstream. The truncated PAX2 mutant In patients 1 and 3, bilateral coloboma limited to the
optic disk was revealed by fundus examination. In patientprotein lacked the major part of the paired domain. The
six-nucleotide deletion (658-663del) in exon 2 resulted 2, the optic disk appeared dysplastic with apparent thick-
ening of the papilla (Fig. 3).in the ablation of two highly conserved amino acids in
the paired domain. These two PAX2 mutations were not Within the kidney, nuclear expression of the protein
was observed in most preserved distal and collectingfound in 100 control chromosomes, indicating that they
were not common polymorphic variants. All nine pa- ducts of patient 3 carrying a 619insGPAX2 mutation
(Fig. 1). The distribution was comparable to that in nor-tients carried two alleles of the (CA)n repeat within in-
tron 9 excluding chromosomic deletion at the PAX2 mal control kidneys. Conversely, in patient 2 carrying
the same mutation, most distal tubules and collectinglocus. Mutation in patients 2 and 3 occurred de novo, as
their parents were shown not to carry the mutation. ducts were PAX2 negative. Of the three patients with
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Fig. 3. Optic disk appearance (left eye) in the
three patients with OMN and PAX2 mutation.
Patients 1 (A) and 3 (B) exhibit characteristic
features of optic disk coloboma with a deep
temporal excavation (arrowheads). In patient
2 (C), the optic disk is dysplastic with thickening
(arrow) and abnormal vessels emergence.
OMN without PAX2 mutation, two had normal expres- compatible with renal dysplasia in some cases and with
sion of PAX2, whereas the expression was reduced in OMN in others. In our study, the finding of PAX2 muta-
the other patient (data not shown). tions in three patients with OMN clearly shows that this
condition can be considered part of the RCS.
As previously shown, PAX2 is expressed in the distalDISCUSSION
tubule and collecting duct, and the expression persists
The pathogenesis of OMN is still unknown. The char-
in adulthood [23]. In one OMN patient, PAX2 expression
acteristic reduction in the number of nephrons could
was preserved, whereas it was not detected in the secondresult from a failure in the process of epithelial transfor-
one with the same 619Gins. Similar findings were obtainedmation of the metanephric blastema or from deficient
in OMN patients without PAX2 mutation, showing thebranching of the ureteric bud, as suggested by the fre-
difficulties in interpreting changes observed in end-stagequent finding of unipapillary or paucipapillary kidneys.
kidneys and the need for animal models [20].Genetic and environmental factors have both been in-
Optic nerve coloboma, a malformation resulting fromcriminated. In recent years, advances in the basic mecha-
incomplete closure of the embryonic optic cup fissure,nisms of developmental biology have provided new in-
may be large, resulting in a more or less serious visualsight into the mechanisms of nephrogenesis, and a start
deficit, or may be limited and asymptomatic [19]. Indeed,has been made toward elucidating the underlying molec-
none of the children studied here had visual impairment,ular controls of this process. For example, it has been
shown that OMN observed in some branchio-oto-renal and repeat fundus examinations were initially considered
patients is due to mutation in the EYA1 gene expressed normal. After careful re-evaluation, mild coloboma was
in the condensing mesenchyme surrounding the “just found in two patients, and mild optic disk dysplasia was
divided” ureteric branchs [3]. found in the third. The detection of these ocular changes,
Pax genes are a family of developmental genes encod- even mild and asymptomatic in the three patients, con-
ing nuclear transcription factors, with a paired domain firms that eye anomalies are a constant feature of PAX2
harboring the DNA binding activity. Pax2 is one of the mutations and that the RCS is the sole clinical expression
first genes expressed during nephrogenesis in the nephric of this gene defect. This is confirmed by previous findings
duct, then in the ureteric branch derivatives, and in the that among a large cohort of patients with optic nerve
condensed metanephric cells that will differentiate into coloboma, PAX2 mutations were detected only in pa-
nephrons [8, 24]. It plays a crucial role during urinary
tients with associated renal malformation [18]. It thus
tract development, as established by mutant mice. Dele-
seems important to search for renal hypoplasia or VURtion of a single Pax2 allele, in Pax21Neu/1 mice, impairs
in patients with coloboma, and conversely to performmetanephric growth and results in a reduction of the
careful eye examination, with specific attention to dis-number of nephrons, often associated with megaureter
crete signs of optic disk anomalies, in patients with appar-suggesting vesicoureteral reflux [10]. Interestingly, the
ently isolated renal hypoplasia.mechanism leading to renal hypoplasia in Pax21Neu/1 mice
In conclusion, our report confirms the critical role ofseems to be enhanced apoptosis of the ureteric epithe-
PAX2 in human renal development and suggests thatlium at E15 [20].
OMN is genetically heterogeneous. Furthermore, thisIn humans, heterozygous PAX2 mutations have been
study extends the phenotypic variability of the RCS asso-reported in patients with optic nerve coloboma associ-
ated with renal hypoplasia [13]. Histologic analysis is ciated with PAX2 mutations in the human.
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